01—Abstract
Summary
Summary of the 8-K filed June 10, 2026. Cited figures are marked; the original filing is the authoritative source.
Biogen Inc. (BIIB) filed an 8-K on June 10, 2026, reporting the final voting results from its 2026 Annual Meeting of Stockholders held on June 9, 2026.
The meeting's primary outcomes included the election of ten directors to the Board and the ratification of PricewaterhouseCoopers LLP as the independent auditor for fiscal year 2026. Additionally, stockholders provided an advisory vote on executive compensation.
Investors can view the detailed voting outcomes for each director nominee, which indicate overwhelming support for most candidates, with a few exceptions receiving notably fewer 'for' votes but still comfortably elected. The ratification of the auditor and the advisory vote on executive compensation also received significant stockholder approval, suggesting general confidence in the company's governance and financial oversight for the upcoming fiscal year.
02—Key points
Key Highlights
- Biogen Inc. held its 2026 Annual Meeting of Stockholders on June 9, 2026.
- Ten nominees were elected to Biogen's Board of Directors to serve until the 2027 annual meeting.
- All ten director nominees received a majority of the votes cast in their favor, with some nominees like Lloyd Minor and Menelas Pangalos receiving particularly high 'for' vote counts.
- PricewaterhouseCoopers LLP was ratified as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.
- The selection of PricewaterhouseCoopers LLP as auditor was overwhelmingly approved by stockholders.
- An advisory vote on executive compensation was approved by a significant majority of stockholders.
- The filing provides detailed vote counts for each director nominee, including 'for', 'against', 'abstentions', and 'broker non-votes'.
03—Questions
Frequently Asked Questions
What were the main outcomes of Biogen's 2026 Annual Meeting of Stockholders?
The primary outcomes were the election of ten directors to the Board of Directors, the ratification of PricewaterhouseCoopers LLP as the independent auditor for fiscal year 2026, and an advisory vote on executive compensation. All proposals received majority approval from stockholders.
How did the director nominees fare in the election?
All ten director nominees were elected. While most received very high 'for' vote counts, nominees Eric K. Rowinsky, Maria C. Freire, Stephen A. Sherwin, Jesus B. Mantas, William A. Hawkins, and Susan K. Langer received fewer 'for' votes compared to others, but still comfortably secured their positions with a majority of votes cast.
Was the company's auditor approved by shareholders?
Yes, the selection of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026, was ratified by stockholders with a substantial majority of 'for' votes.
What is the general sentiment from the advisory vote on executive compensation?
The advisory vote on executive compensation was approved by a significant majority of stockholders, indicating general shareholder support for the company's executive pay practices.
04—Continue